Purchase of Own Securities

GlaxoSmithKline PLC 07 June 2004 GlaxoSmithKline PLC GlaxoSmithKline plc (the "Company") announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 17 May 2004 it purchased 439,000 of it's Ordinary shares of 25 pence each ("shares") on 7 June 2004 at a price of 1137.66 pence per share. The Company intends to hold these shares in Treasury. Following the purchase of these shares, the Company holds 19,219,000 of it's shares in Treasury and has 5,914,332,837 shares in issue (excluding Treasury shares). This announcement does not constitute, or form part of, an offer or any solicitation of an offer to purchase or subscribe for securities in any jurisdiction. This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings